These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

334 related articles for article (PubMed ID: 39200241)

  • 1. Circadian Interventions in Preclinical Models of Huntington's Disease: A Narrative Review.
    Dell'Angelica D; Singh K; Colwell CS; Ghiani CA
    Biomedicines; 2024 Aug; 12(8):. PubMed ID: 39200241
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blue light therapy improves circadian dysfunction as well as motor symptoms in two mouse models of Huntington's disease.
    Wang HB; Whittaker DS; Truong D; Mulji AK; Ghiani CA; Loh DH; Colwell CS
    Neurobiol Sleep Circadian Rhythms; 2017 Jan; 2():39-52. PubMed ID: 31236494
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sleep, Circadian Rhythms, and Cognitive Dysfunction in Huntington's Disease.
    Fitzgerald ES; Stout JC; Glikmann-Johnston Y; Anderson C; Jackson ML
    J Huntingtons Dis; 2023; 12(3):293-304. PubMed ID: 37599535
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circadian-based Treatment Strategy Effective in the BACHD Mouse Model of Huntington's Disease.
    Whittaker DS; Loh DH; Wang HB; Tahara Y; Kuljis D; Cutler T; Ghiani CA; Shibata S; Block GD; Colwell CS
    J Biol Rhythms; 2018 Oct; 33(5):535-554. PubMed ID: 30084274
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sleep Disorders in Huntington's Disease.
    Herzog-Krzywoszanska R; Krzywoszanski L
    Front Psychiatry; 2019; 10():221. PubMed ID: 31031659
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dietary ketosis improves circadian dysfunction as well as motor symptoms in the BACHD mouse model of Huntington's disease.
    Whittaker DS; Tamai TK; Bains RS; Villanueva SAM; Luk SHC; Dell'Angelica D; Block GD; Ghiani CA; Colwell CS
    Front Nutr; 2022; 9():1034743. PubMed ID: 36407529
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Do Disruptions in the Circadian Timing System Contribute to Autonomic Dysfunction in Huntington's Disease?
    Park S; Colwell CS
    Yale J Biol Med; 2019 Jun; 92(2):291-303. PubMed ID: 31249490
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circadian and sleep disorder in Huntington's disease.
    Morton AJ
    Exp Neurol; 2013 May; 243():34-44. PubMed ID: 23099415
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Time-Restricted Feeding Improves Circadian Dysfunction as well as Motor Symptoms in the Q175 Mouse Model of Huntington's Disease.
    Wang HB; Loh DH; Whittaker DS; Cutler T; Howland D; Colwell CS
    eNeuro; 2018; 5(1):. PubMed ID: 29302618
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sleep Disorders and Circadian Disruption in Huntington's Disease.
    Saade-Lemus S; Videnovic A
    J Huntingtons Dis; 2023; 12(2):121-131. PubMed ID: 37424473
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Degeneration of ipRGCs in Mouse Models of Huntington's Disease Disrupts Non-Image-Forming Behaviors Before Motor Impairment.
    Lin MS; Liao PY; Chen HM; Chang CP; Chen SK; Chern Y
    J Neurosci; 2019 Feb; 39(8):1505-1524. PubMed ID: 30587542
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early and progressive circadian abnormalities in Huntington's disease sheep are unmasked by social environment.
    Morton AJ; Rudiger SR; Wood NI; Sawiak SJ; Brown GC; Mclaughlan CJ; Kuchel TR; Snell RG; Faull RL; Bawden CS
    Hum Mol Genet; 2014 Jul; 23(13):3375-83. PubMed ID: 24488771
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sleep and circadian dysfunction in neurodegenerative disorders: insights from a mouse model of Huntington's disease.
    Kuljis D; Schroeder AM; Kudo T; Loh DH; Willison DL; Colwell CS
    Minerva Pneumol; 2012 Sep; 51(3):93-106. PubMed ID: 23687390
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Paradoxical function of orexin/hypocretin circuits in a mouse model of Huntington's disease.
    Williams RH; Morton AJ; Burdakov D
    Neurobiol Dis; 2011 Jun; 42(3):438-45. PubMed ID: 21324360
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Progressive gene dose-dependent disruption of the methamphetamine-sensitive circadian oscillator-driven rhythms in a knock-in mouse model of Huntington's disease.
    Ouk K; Aungier J; Morton AJ
    Exp Neurol; 2016 Dec; 286():69-82. PubMed ID: 27646506
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dietary fasting and time-restricted eating in Huntington's disease: therapeutic potential and underlying mechanisms.
    Wells RG; Neilson LE; McHill AW; Hiller AL
    Transl Neurodegener; 2024 Apr; 13(1):17. PubMed ID: 38561866
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Longitudinal analysis of the electroencephalogram and sleep phenotype in the R6/2 mouse model of Huntington's disease.
    Fisher SP; Black SW; Schwartz MD; Wilk AJ; Chen TM; Lincoln WU; Liu HW; Kilduff TS; Morairty SR
    Brain; 2013 Jul; 136(Pt 7):2159-72. PubMed ID: 23801738
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multidisciplinary rehabilitation reduces hypothalamic grey matter volume loss in individuals with preclinical Huntington's disease: A nine-month pilot study.
    Bartlett DM; Dominguez D JF; Lazar AS; Kordsachia CC; Rankin TJ; Lo J; Govus AD; Power BD; Lampit A; Eastwood PR; Ziman MR; Cruickshank TM
    J Neurol Sci; 2020 Jan; 408():116522. PubMed ID: 31665619
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The cognitive burden in Huntington's disease: pathology, phenotype, and mechanisms of compensation.
    Papoutsi M; Labuschagne I; Tabrizi SJ; Stout JC
    Mov Disord; 2014 Apr; 29(5):673-83. PubMed ID: 24757115
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circadian dysfunction in the Q175 model of Huntington's disease: Network analysis.
    Smarr B; Cutler T; Loh DH; Kudo T; Kuljis D; Kriegsfeld L; Ghiani CA; Colwell CS
    J Neurosci Res; 2019 Dec; 97(12):1606-1623. PubMed ID: 31359503
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.